Torren Management’s Tenaya Therapeutics TNYA Stock Holding History

Torren Management’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,673	Closed	-$2.61K	–	1422
2025 Q4	$2.61K	Buy	+3,673	New	+$5K	﹤0.01%	1015

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Torren Management's TNYA Position: Q1 2026 in Review

Torren Management sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 3,673 shares — an estimated $2.61K sold.

Torren Management first reported a position in TNYA in Q4 2025 and held it in 1 quarter. The position peaked at $2.61K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Torren Management reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
Torren Management sold 3,673 Tenaya Therapeutics shares in Q1 2026, an estimated $2.61K.
Torren Management first reported a position in Tenaya Therapeutics in Q4 2025 and held it in 1 quarter.
Torren Management's Tenaya Therapeutics position peaked at $2.61K in Q4 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.